Merck KGaA (Darmstadt) setzt telemedizinische Patientenmonitoring-Plattform von PRA mit seinem Behandlungssystem mit humanen Wachstumshormonen ein

    NEXT STORY
    Aprea Therapeutics Receives FDA Orphan Drug Designation for Eprenetapopt for the Treatment of Acute Myeloid Leukemia (AML)
    PREV STORY
    Veterinary CRO Market Size to Reach $1.26 Bn, Globally, by 2027 at 7.7% CAGR: Allied Market Research
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    aTyr Pharma Strengthens Board of Directors with the Appointment of Two New Members

    author_avatar
    NASDAQ Market News

    Telo Genomics Announces that Positive Results of Smoldering Multiple Myeloma Study Selected for Online Publication Within ASH 2020 Proceedings

    author_avatar
    NASDAQ Market News

    Bioxytran Positioned to Detect and Treat Stroke and Neuropathologies

    author_avatar
    NASDAQ Market News